Search Results - "Kaur, Parjeet"

Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial) by Kuchay, Mohammad S., Krishan, Sonal, Mishra, Sunil K., Choudhary, Narendra S., Singh, Manish K., Wasir, Jasjeet S., Kaur, Parjeet, Gill, Harmandeep K., Bano, Tarannum, Farooqui, Khalid J., Mithal, Ambrish

“…Aims/hypothesis Liraglutide, a daily injectable glucagon-like peptide-1 receptor (GLP-1r) agonist, has been shown to reduce liver fat content (LFC) in humans…”
Get full text

Anticancer Drug-induced Thyroid Dysfunction by Bhattacharya, Saptarshi, Goyal, Alpesh, Kaur, Parjeet, Singh, Randeep, Kalra, Sanjay

“…Cancer immunotherapy and targeted therapy, though less toxic than conventional chemotherapy, can increase the risk of thyroid dysfunction. Immune checkpoint…”
Get full text

Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism by Kuchay, Mohammad Shafi, Mathew, Anu, Kaur, Parjeet, Mishra, Sunil Kumar

“…Severe hypercalcemia is a medical emergency that requires immediate and aggressive management. Primary hyperparathyroidism (PHPT) often causes severe…”
Get full text

Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial) by Kuchay, Mohammad Shafi, Khatana, Pushpender, Mishra, Mitali, Surendran, Parvathi, Kaur, Parjeet, Wasir, Jasjeet Singh, Gill, Harmandeep Kaur, Singh, Apanshu, Jain, Rujul, Kohli, Chhavi, Bakshi, Gazal, Radhika, Vishnupriya, Saheer, Sumayya, Singh, Manish Kumar, Mishra, Sunil Kumar

“…Aims To examine the efficacy and safety of dapagliflozin in the treatment of hyperglycemia in cardiac surgery patients with type 2 diabetes (T2D). Methods…”
Get full text

Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes by Kuchay, Mohammad Shafi, Choudhary, Narendra Singh, Mishra, Sunil Kumar, Bano, Tarannum, Gagneja, Sakshi, Mathew, Anu, Singh, Manish Kumar, Kaur, Parjeet, Gill, Harmandeep Kaur, Wasir, Jasjeet Singh, Sud, Randhir, Mithal, Ambrish

“…Background and Aim Type 2 diabetes (T2D) in associated with higher prevalence and worse outcomes of nonalcoholic fatty liver disease (NAFLD). However, data…”
Get full text

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting by Kaur, Parjeet, Mahendru, Shama, Mithal, Ambrish

“…Background: Long-term efficacy of liraglutide, a glucagon-like peptide-1 analog, on body weight and glycemic control has not been studied in Indian Type 2…”
Get full text

Adverse effect profile and effectiveness of sodium glucose co-transporter 2 inhibitors (SGLT2i) - A prospective real-world setting study by Gill, Harmandeep, Kaur, Parjeet, Mahendru, Shama, Mithal, Ambrish

“…Background: Clinical trials have shown promising results in terms of glycemic control and weight reduction with the use of sodium glucose co-transporter 2…”
Get full text

Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: Data from single institution in India by Kaur, Parjeet, Gattani, Raghav, Singhal, Alka, Sarin, Deepak, Arora, Sowrabh, Mithal, Ambrish

“…Context: Preoperative localization of parathyroid adenoma is essential in deciding the surgical approach of parathyroidectomy. Aim: To describe clinical and…”
Get full text

Vitamin D and insulin resistance in postmenopausal Indian women by Agarwal, Niti, Mithal, Ambrish, Kaur, Parjeet, Dhingra, Vibha, Godbole, M M, Shukla, M

“…The purpose of this study is to investigate the association of the serum 25-hydroxyvitamin D (25-OHD) level with markers of insulin resistance (IR) in…”
Get full text

Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India by Kaur, Parjeet, Mishra, Sunil Kumar, Mithal, Ambrish, Saxena, Meenal, Makkar, Anshu, Sharma, Pooja

“…GLP-1 receptor agonists (GLP-1 RA) are unique antidiabetic agents that have the ability to lower blood glucose without causing hypoglycemia, while at the same…”
Get full text

Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency by Kaur, Parjeet, Mishra, Sunil Kumar, Mithal, Ambrish

“…Summary Background Vitamin D toxicity, often considered rare, can be life‐threatening and associated with substantial morbidity, if not identified promptly…”
Get full text

Osteoporosis in Asia: A Call to Action by Mithal, Ambrish, Kaur, Parjeet

“…Asia is witnessing a rapid growth in its aging population. Yet osteoporosis in this region has received relatively little attention. Hip fracture rates have…”
Get full text

Usage of pioglitazone at Medanta, the Medicity by Mithal, Ambrish, Kaur, Parjeet, Bansal, Beena, Mishra, Sunil Kumar, Wasir, Jasjeet S, Jevalikar, Ganesh, Mahendru, Shama

“…Pioglitazone improves glycemic control by acting as an insulin sensitizer and is used in the management of Type 2 diabetes mellitus. Pioglitazone has recently…”
Get full text

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) by Kuchay, Mohammad Shafi, Krishan, Sonal, Mishra, Sunil Kumar, Farooqui, Khalid Jamal, Singh, Manish Kumar, Wasir, Jasjeet Singh, Bansal, Beena, Kaur, Parjeet, Jevalikar, Ganesh, Gill, Harmendeep Kaur, Choudhary, Narendra Singh, Mithal, Ambrish

“…Sodium-glucose cotransporter 2 (SGLT-2) inhibitors have been shown to reduce liver fat in rodent models. Data regarding the effect of SGLT-2 inhibitors on…”
Get full text

Effect of two different doses of oral cholecalciferol supplementation on serum 25-hydroxy-vitamin D levels in healthy Indian postmenopausal women: A randomized controlled trial by Agarwal, Niti, Mithal, Ambrish, Dhingra, Vibha, Kaur, Parjeet, Godbole, Madan, Shukla, Manoj

“…Aim: To compare the effect of two different doses (500 and 1000 IU/day) of oral vitamin D3 (cholecalciferol) on serum 25-hydroxy vitamin D [25(OH)D] levels in…”
Get full text

EFFECT OF GLUTEN-FREE DIET ON METABOLIC CONTROL AND ANTHROPOMETRIC PARAMETERS IN TYPE 1 DIABETES WITH SUBCLINICAL CELIAC DISEASE: A RANDOMIZED CONTROLLED TRIAL by Kaur, Parjeet, Agarwala, Anuja, Makharia, Govind, Bhatnagar, Shinjini, Tandon, Nikhil

“…It is unclear whether the institution of gluten-free diet (GFD) is beneficial in patients with type 1 diabetes (T1DM) and subclinical celiac disease (CD). Our…”
Get more information

mRNA expression of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic and asymptomatic primary hyperparathyroidism by Kaur, Parjeet, Hegde, Dwijraj, Singh, Priyanka, Gautam, Dheeraj, Sarin, Deepak, Bhadada, Sanjay, Mithal, Ambrish

“…The exact underlying mechanism for the differential clinical profiles of symptomatic and asymptomatic primary hyperparathyroidism (PHPT) patients has not been…”
Get full text

Increased prevalence of self-reported fractures in Asian Indians with diabetes: Results from the ICMR-INDIAB population based cross-sectional study by Kaur, Parjeet, Anjana, Ranjit Mohan, Tandon, Nikhil, Singh, Manish Kumar, Mohan, Viswanathan, Mithal, Ambrish

“…Diabetes mellitus (DM), has been associated with increased fracture risk. However, there are no data pertaining to the prevalence of fractures for patients…”
Get full text

Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk by Kuchay, Mohammad Shafi, Martínez-Montoro, José Ignacio, Kaur, Parjeet, Fernández-García, José Carlos, Ramos-Molina, Bruno

“…In the last few decades, the loss of skeletal muscle mass and function, known as sarcopenia, has significantly increased in prevalence, becoming a major global…”
Get full text

Day 2 neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for prediction of delayed cerebral ischemia in subarachnoid hemorrhage by Bolton, William S, Gharial, Parjeet Kaur, Akhunbay-Fudge, Christopher, Chumas, Paul, Mathew, Ryan K, Anderson, Ian A

“…Recent evidence has suggested that an admission neutrophil-to-lymphocyte ratio (NLR) of ≥ 5.9 predicts delayed cerebral ischemia (DCI) in aneurysmal…”
Get full text